Ad blocking detected

Thank you for visiting CanadianInsider.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). Private browsing Firefox users should be able to disable tracking protection while visiting our website. Visit Mozilla support for more information. If you do not believe you have any ad-blocking software on your browser, you may want to try another browser, computer or internet service provider. Alternatively, you may consider the following if you want an ad-free experience.

Canadian Insider Ultra Club
$432/ year*
Daily Morning INK newsletter
+3 months archive
Canadian Market INK weekly newsletter
+3 months archive
30 publication downloads per month from the PDF store
Top 20 Gold, Top 30 Energy, Top 40 Stock downloads from the PDF store
All benefits of basic registration
No 3rd party display ads
JOIN THE CLUB

* Price is subject to applicable taxes.

Paid subscriptions and memberships are auto-renewing unless cancelled (easily done via the Account Settings Membership Status page after logging in). Once cancelled, a subscription or membership will terminate at the end of the current term.

Globe Newswire News Releases

May 08, 2024 07:30 ET
BioRestorative Therapies Enhances Preclinical Metabolic Program with a Novel Exosome-Based Biologic Targeting Obesity
BioRestorative Therapies, Inc. (“BioRestorative”, “BRTX” or the “Company”) (NASDAQ:BRTX), a clinical stage company focused on stem cell-based therapies, today announced its development of a novel exosome-based biologic program targeting obesity....
May 08, 2024 07:30 ET
Cytokinetics Announces Start of CEDAR-HCM, a Clinical Trial of Aficamten in a Pediatric Population With Symptomatic Obstructive Hypertrophic Cardiomyopathy
Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that CEDAR-HCM (Clinical Evaluation of Dosing with Aficamten to Reduce Obstruction in a Pediatric Population in HCM), a clinical trial of aficamten in a pediatric population with symptomatic...
May 08, 2024 07:30 ET
Cytokinetics Announces Topline Data From Phase 1 Clinical Study of CK-4021586
Cytokinetics, Incorporated (Nasdaq: CYTK) today announced topline data from the Phase 1 study of CK-4021586 (CK-586). The study met its primary and secondary objectives to assess the safety, tolerability and pharmacokinetics (PK) of single and...
May 08, 2024 07:30 ET
FitLife Brands Announces First Quarter Earnings Call and its Participation at Sidoti Virtual Investor Conference and Provides Operational Update
FitLife Brands, Inc. (“FitLife,” or the “Company”) (Nasdaq: FTLF), a provider of innovative and proprietary nutritional supplements and wellness products, today announced that it will participate in the Sidoti Virtual Investor Conference on...
May 08, 2024 07:30 ET
Genie Energy Announces First Quarter 2024 Results
Genie Energy, Ltd. (NYSE: GNE), a leading retail energy and renewable energy solutions provider, today announced results for the first quarter of 2024.  Michael Stein, chief executive officer of Genie Energy, commented:...
May 08, 2024 07:30 ET
HPQ Silicon Signs MOU With Impact Funding Europe for Collaboration on EU Funding Programs
HPQ Silicon Inc. (“HPQ” or the “Company”) (TSX-V: HPQ) (OTCQB: HPQFF) (FRA: O08), a technology company specializing in green engineering of silica and silicon-based materials, announces the signing of a Memorandum of Understanding (MOU) with Impact...
May 08, 2024 07:30 ET
InflaRx Reports First Quarter 2024 Financial Results and Provides Business Update
InflaRx N.V. (Nasdaq: IFRX), a biopharmaceutical company pioneering anti-inflammatory therapeutics targeting the complement system, today announced financial results for the three months ended March 31, 2024, and provided an operating update....
May 08, 2024 07:30 ET
Metasphere Labs Inc. Finalizes Strategic Partnership with Bot Ventures Inc. to Lead in Bitcoin-Based Decentralized Identity Solutions
Metasphere Labs Inc. ("Metasphere" or the "Company") (Cboe Canada: LABZ) (OTC: LABZF) (FRA: H1N) is excited to announce a definitive agreement with Bot Ventures Inc. (“Bot Ventures”), an innovator in the identity, naming, and verification space...
May 08, 2024 07:28 ET
WEMADE and WEMIX Win “Best Web3 Gaming” at MENA Games Industry Awards 2024
WEMADE and WEMIX were honored with the prestigious "BEST WEB3 GAMING '' award at the MENA Games Industry Awards 2024. The awards celebrate the best of the region's thriving gaming sector, and as the sole web3-focused award, the "BEST WEB3...
May 08, 2024 07:25 ET
Alterity Therapeutics Phase 2 Data Monitoring Committee Recommends Continuing Clinical Trial as Planned After Third Review
Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) (“Alterity” or “the Company”), a biotechnology company dedicated to developing disease modifying treatments for neurodegenerative diseases, today announced that an independent Data Monitoring Committee...
May 08, 2024 07:25 ET
Ladybug Signs LOI to Purchase Ecommerce Site from Your Supplement Supply Store Ltd.
Ladybug Resource Group, Inc. (OTC PINK: LBRG), now operating under the brand name Ladybug NutraTech, is excited to announce the signing of a Letter of Intent for the acquisition of a leading e-commerce platform from Your Supplement Supply Store...
May 08, 2024 07:16 ET
WTW boosts global cyber facility with increased capacity and broader coverage options
WTW (NASDAQ: WTW), a leading global advisory, broking and solutions company, today announces strategic enhancements to its global cyber facility. Following a successful launch in January 2023, WTW’s CyXS facility, a global solution for excess cyber...
May 08, 2024 07:05 ET
Gilat Reports First Quarter 2024 Results
Gilat Satellite Networks Ltd. (NASDAQ: GILT, TASE: GILT), a worldwide leader in satellite networking technology, solutions and services, today reported its results for the first quarter, ended March 31, 2024. First Quarter 2024 Financial...
May 08, 2024 07:00 ET
GDS to Report First Quarter 2024 Financial Results Before the Open of the U.S. Market on May 22, 2024
GDS Holdings Limited (“GDS Holdings”, “GDS” or the “Company”) (NASDAQ: GDS; HKEX: 9698), a leading developer and operator of high-performance data centers in China and South East Asia, today announced that it will report its first quarter 2024...
May 08, 2024 07:00 ET
Chemomab Therapeutics Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Price Rule
Chemomab Therapeutics Ltd. (Nasdaq: CMMB) (Chemomab), a clinical stage biotechnology company developing innovative therapeutics for fibro-inflammatory diseases with high unmet need, today announced that it received formal notification from...
May 08, 2024 07:00 ET
Inception Growth Acquisition Limited Announces Additional Contribution to Trust Account to Extend Business Combination Period
Inception Growth Acquisition Limited (NASDAQ: IGTA, the “Company”), a publicly traded special purpose acquisition company, announced today that on May 6, 2024, the Company deposited $100,000 into the Company’s trust account (the “Trust Account”)...
May 08, 2024 07:00 ET
OKYO Pharma Announces Participation in May 2024 Investor Conferences
OKYO Pharma Limited (NASDAQ: OKYO), a clinical-stage biopharmaceutical company developing innovative ocular therapies for the treatment of inflammatory dry eye disease (DED), a multi-billion-dollar market, and anterior ocular segment diseases...
May 08, 2024 07:00 ET
PolyPid Provides Corporate Update and Reports First Quarter 2024 Financial Results
PolyPid Ltd. (Nasdaq: PYPD) (“PolyPid” or the “Company”), a late-stage biopharma company aiming to improve surgical outcomes, today provided a corporate update and reported financial results for the three months ended March 31, 2024. Recent...
May 08, 2024 07:00 ET
R1 RCM Reports First Quarter 2024 Results
R1 RCM Inc. (NASDAQ: RCM) (“R1” or the “Company”), a leading provider of technology-driven solutions that transform the financial performance and patient experience for health systems, hospitals, and physician groups, today announced results for...